CERo Therapeutics Inc.
(CERO)
undefined
undefined%
At close: undefined
0.06
2.26%
Pre-market Jan 06, 2025, 07:32 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -2.54K | -667.74K | -315.55K |
| Depreciation & Amortization | n/a | 1.07M | 735.47K |
| Stock-Based Compensation | n/a | 381.07K | 287.74K |
| Other Working Capital | 197.76 | 2.41M | -365.08K |
| Other Non-Cash Items | 814.87 | -2.84M | -16.48K |
| Deferred Income Tax | n/a | n/a | n/a |
| Change in Working Capital | 197.76 | 2.41M | -365.08K |
| Operating Cash Flow | -1.52K | -1.09M | -697.11K |
| Capital Expenditures | 4.00 | -694.23K | -612.57K |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | -14.34M | -325.00K | -178.50M |
| Sales Maturities Of Investments | 5.64M | n/a | n/a |
| Other Investing Acitivies | 8.69M | 181.16M | -306.00K |
| Investing Cash Flow | -7.94K | 180.84M | -178.50M |
| Debt Repayment | 905.00K | 650.00K | n/a |
| Common Stock Repurchased | -33.48K | -139.35M | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | -904.10K | -139.21M | 60.26K |
| Financial Cash Flow | -32.58K | -138.70M | 180.30M |
| Net Cash Flow | -42.04K | 41.04M | -28.77M |
| Free Cash Flow | -1.52K | -1.79M | -1.31M |